International Society on Thrombosis and Haemostasis - 34th Congress, 2026 (ISTH) 11 - 15 July 2026

Mim8 (denecimig) prophylaxis in adults and adolescents with haemophilia A with or without inhibitors: Interim results from the FRONTIER4 long-term safety and efficacy study

Authors :

Jerzy Windyga¹, Llenalia Fernández², Johannes Oldenburg³, Maria Mancuso⁴, Davide Matino⁵, Ilgiz Rakhmatullin², Tadashi Matsushita⁶

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Rare Blood Disorders

Congress oral presentation

Mim8

Are you a healthcare professional?